PerpEquities

Equity

Revolution Medicines, Inc. (RVMD) perpetual futures

Revolution Medicines, Inc. is a clinical-stage precision oncology company developing targeted therapies for RAS-driven cancers, including RAS(ON) inhibitors and SHP2 inhibitors.

-0.3%NASDAQ closed
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:RVMD

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

0/1 live markets
Venues
1
Live markets
0/1
24h volume
$0
Open interest
$0
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D-0.30%
5D-5.54%
1M+14.68%
6M+108.21%
YTD+162.69%
1Y+426.10%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeRVMD-USDTPlanned------USDT-

Embed this asset

RVMD perpetuals · perpequities.comRVMD perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/rvmd-perp"><img src="https://perpequities.com/badge/rvmd-perp.svg" width="240" height="64" alt="RVMD perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

-
No live data-

Company data

Company fundamentals

Updated 2h ago
Market cap
$44.5B
Updated 2h ago
Revenue
$0
Trailing 12 months
Revenue growth
-
Next fiscal year
Profit margin
0.0%
P/E
-23.6
Peer P/E -6.0
Free cash flow
-$1.6B
Trailing 12 months
More metrics
Net income
-$1.8B
Trailing 12 months
P/S
-
Peer P/E
-6.0
Similar listed perps
Revenue estimate
$165.8M
Next fiscal year
Earnings
2026-11-04
Revenue est. $16.9M · Updated 2h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$0
Net margin0.0%
Free cash flow-$913.7M
Net debt-$225M
2020$43M
2021$29.4M
2022$35.4M
2023$11.6M
2024$0
2025$0
PeriodRevenueGrowthNet incomeFCF
2020$43M-14%-$108.2M-$103M
2021$29.4M-32%-$187.1M-$153.7M
2022$35.4M+20%-$248.7M-$235.2M
2023$11.6M-67%-$436.4M-$358.3M
2024$0-100%-$600.1M-$567.7M
2025$0--$1.1B-$913.7M
PeriodGross marginOperating marginNet marginROEROA
2020+100.0%-257.5%-251.6%-22.8%-19.1%
2021+100.0%-639.7%-636.6%-31.0%-25.4%
2022+100.0%-730.0%-703.0%-36.3%-30.6%
2023+100.0%-4,207.1%-3,768.3%-23.9%-21.2%
20240.0%0.0%0.0%-26.5%-23.5%
20250.0%0.0%0.0%-69.3%-48.0%
PeriodCashDebtNet debtCurrent ratio
2020$104.3M$32.7M-$71.6M9.63
2021$108.5M$66.6M-$41.9M9.77
2022$161.4M$64.2M-$97.2M10.65
2023$696.1M$87.9M-$608.2M13.06
2024$543.1M$135.8M-$407.2M14.20
2025$383.7M$158.7M-$225M7.14
PeriodMarket capEnterprise valueP/SP/E
2020$2.6B$2.6B61.3-24.4
2021$1.8B$1.8B62.4-10.2
2022$1.9B$1.8B54.3-7.7
2023$3.2B$2.6B280.2-7.4
2024$7.3B$6.9B0.0-12.2
2025$15.1B$14.9B0.0-13.4
Q3 2024$0
Q4 2024$0
Q1 2025$0
Q2 2025$0
Q3 2025$0
Q4 2025$0
Q1 2026$0
Q2 2026$0
PeriodRevenueGrowthNet incomeFCF
Q3 2024$0--$156.3M-$133.9M
Q4 2024$0-100%-$194.6M-$139.5M
Q1 2025$0--$213.4M-$197.7M
Q2 2025$0--$247.8M-$229.2M
Q3 2025$0--$305.2M-$210.7M
Q4 2025$0--$364.9M-$276.2M
Q1 2026$0--$453.8M-$355.7M
Q2 2026$0--$644.4M-$745.3M
PeriodGross marginOperating marginNet marginROEROA
Q3 20240.0%0.0%0.0%-10.0%-8.9%
Q4 20240.0%0.0%0.0%-8.6%-7.6%
Q1 20250.0%0.0%0.0%-10.3%-9.0%
Q2 20250.0%0.0%0.0%-13.3%-10.2%
Q3 20250.0%0.0%0.0%-19.1%-13.6%
Q4 20250.0%0.0%0.0%-22.4%-15.5%
Q1 20260.0%0.0%0.0%-30.3%-20.1%
Q2 20260.0%0.0%0.0%-24.7%-14.9%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$201.3M$86.7M-$114.6M14.24
Q4 2024$543.1M$135.8M-$407.2M14.20
Q1 2025$333.6M$134.3M-$199.2M13.46
Q2 2025$402.4M$132.8M-$269.7M11.79
Q3 2025$217.4M$158.5M-$59M8.05
Q4 2025$383.7M$158.7M-$225M7.14
Q1 2026$440.9M$437.3M-$3.7M6.80
Q2 2026$815.4M$641.9M-$173.5M11.38
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$7.6B$7.5B0.0-12.1
Q4 2024$7.3B$6.9B0.0-9.7
Q1 2025$6.7B$6.5B0.0-7.8
Q2 2025$6.9B$6.7B0.0-7.0
Q3 2025$8.8B$8.8B0.0-7.3
Q4 2025$15.1B$14.9B0.0-10.5
Q1 2026$19.3B$19.3B0.0-10.6
Q2 2026$39.5B$39.3B0.0-15.3
Historical value series
Revenue
Q3 2023: $0Q4 2023: $742KQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2023Q2 2026
Net income
Q3 2023: -$108.4MQ4 2023: -$161.5MQ1 2024: -$116MQ2 2024: -$133.2MQ3 2024: -$156.3MQ4 2024: -$194.6MQ1 2025: -$213.4MQ2 2025: -$247.8MQ3 2025: -$305.2MQ4 2025: -$364.9MQ1 2026: -$453.8MQ2 2026: -$644.4MQ3 2023Q2 2026
EBITDA
Q3 2023: -$110.2MQ4 2023: -$129.5MQ1 2024: -$113.2MQ2 2024: -$130.4MQ3 2024: -$153.4MQ4 2024: -$191.9MQ1 2025: -$209.7MQ2 2025: -$244MQ3 2025: -$289.4MQ4 2025: -$348.3MQ1 2026: -$437.1MQ2 2026: -$620.6MQ3 2023Q2 2026
Free cash flow
Q3 2023: -$103MQ4 2023: -$122.9MQ1 2024: -$163.7MQ2 2024: -$130.6MQ3 2024: -$133.9MQ4 2024: -$139.5MQ1 2025: -$197.7MQ2 2025: -$229.2MQ3 2025: -$210.7MQ4 2025: -$276.2MQ1 2026: -$355.7MQ2 2026: -$745.3MQ3 2023Q2 2026
EPS
Q3 2023: -$0.99Q4 2023: -$1.14Q1 2024: -$0.7Q2 2024: -$0.81Q3 2024: -$0.94Q4 2024: -$1.13Q1 2025: -$1.13Q2 2025: -$1.31Q3 2025: -$1.61Q4 2025: -$1.9Q1 2026: -$2.29Q2 2026: -$3.06Q3 2023Q2 2026
Cash / Debt
Q3 2023 · Cash: $358.4MQ3 2023 · Debt: $62.8MQ4 2023 · Cash: $696.1MQ4 2023 · Debt: $87.9MQ1 2024 · Cash: $288.4MQ1 2024 · Debt: $88MQ2 2024 · Cash: $275.7MQ2 2024 · Debt: $87.4MQ3 2024 · Cash: $201.3MQ3 2024 · Debt: $86.7MQ4 2024 · Cash: $543.1MQ4 2024 · Debt: $135.8MQ1 2025 · Cash: $333.6MQ1 2025 · Debt: $134.3MQ2 2025 · Cash: $402.4MQ2 2025 · Debt: $132.8MQ3 2025 · Cash: $217.4MQ3 2025 · Debt: $158.5MQ4 2025 · Cash: $383.7MQ4 2025 · Debt: $158.7MQ1 2026 · Cash: $440.9MQ1 2026 · Debt: $437.3MQ2 2026 · Cash: $815.4MQ2 2026 · Debt: $641.9MQ3 2023Q2 2026
CashDebt
Profitability
Q3 2023 · Gross margin: 0.0%Q4 2023 · Gross margin: +100.0%Q1 2024 · Gross margin: 0.0%Q2 2024 · Gross margin: 0.0%Q3 2024 · Gross margin: 0.0%Q4 2024 · Gross margin: 0.0%Q1 2025 · Gross margin: 0.0%Q2 2025 · Gross margin: 0.0%Q3 2025 · Gross margin: 0.0%Q4 2025 · Gross margin: 0.0%Q1 2026 · Gross margin: 0.0%Q2 2026 · Gross margin: 0.0%Q3 2023 · Operating margin: 0.0%Q4 2023 · Operating margin: -24,256.5%Q1 2024 · Operating margin: 0.0%Q2 2024 · Operating margin: 0.0%Q3 2024 · Operating margin: 0.0%Q4 2024 · Operating margin: 0.0%Q1 2025 · Operating margin: 0.0%Q2 2025 · Operating margin: 0.0%Q3 2025 · Operating margin: 0.0%Q4 2025 · Operating margin: 0.0%Q1 2026 · Operating margin: 0.0%Q2 2026 · Operating margin: 0.0%Q3 2023 · Net margin: 0.0%Q4 2023 · Net margin: -21,770.5%Q1 2024 · Net margin: 0.0%Q2 2024 · Net margin: 0.0%Q3 2024 · Net margin: 0.0%Q4 2024 · Net margin: 0.0%Q1 2025 · Net margin: 0.0%Q2 2025 · Net margin: 0.0%Q3 2025 · Net margin: 0.0%Q4 2025 · Net margin: 0.0%Q1 2026 · Net margin: 0.0%Q2 2026 · Net margin: 0.0%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth
Q4 2024: -100.0%Q3 2023Q2 2026
Shares outstanding
Q3 2023: 109.2MQ4 2023: 141.2MQ1 2024: 164.7MQ2 2024: 165.1MQ3 2024: 166.8MQ4 2024: 167.7MQ1 2025: 188.1MQ2 2025: 188.1MQ3 2025: 189.2MQ4 2025: 190.1MQ1 2026: 198.1MQ2 2026: 210.9MQ3 2023Q2 2026
Valuation
Q3 2023 · P/E: -7.0Q4 2023 · P/E: -6.3Q1 2024 · P/E: -11.3Q2 2024 · P/E: -12.0Q3 2024 · P/E: -12.1Q4 2024 · P/E: -9.7Q1 2025 · P/E: -7.8Q2 2025 · P/E: -7.0Q3 2025 · P/E: -7.3Q4 2025 · P/E: -10.5Q1 2026 · P/E: -10.6Q2 2026 · P/E: -15.3Q3 2023 · P/S: 0.0Q4 2023 · P/S: 5,457.1Q1 2024 · P/S: 0.0Q2 2024 · P/S: 0.0Q3 2024 · P/S: 0.0Q4 2024 · P/S: 0.0Q1 2025 · P/S: 0.0Q2 2025 · P/S: 0.0Q3 2025 · P/S: 0.0Q4 2025 · P/S: 0.0Q1 2026 · P/S: 0.0Q2 2026 · P/S: 0.0Q3 2023Q2 2026
P/EP/S
Revenue
2018: $20.2M2019: $50M2020: $43M2021: $29.4M2022: $35.4M2023: $11.6M2024: $02025: $020182025
Net income
2018: -$41.8M2019: -$47.7M2020: -$108.2M2021: -$187.1M2022: -$248.7M2023: -$436.4M2024: -$600.1M2025: -$1.1B20182025
EBITDA
2018: -$39.9M2019: -$48.6M2020: -$101.9M2021: -$179.7M2022: -$239.5M2023: -$430.3M2024: -$589M2025: -$1.1B20182025
Free cash flow
2018: -$286K2019: -$52.2M2020: -$103M2021: -$153.7M2022: -$235.2M2023: -$358.3M2024: -$567.7M2025: -$913.7M20182025
EPS
2018: -$1.152019: -$1.312020: -$1.622021: -$2.472022: -$3.082023: -$3.862024: -$3.582025: -$5.9520182025
Cash / Debt
2018 · Cash: $69.6M2018 · Debt: $147K2019 · Cash: $16.7M2019 · Debt: $02020 · Cash: $104.3M2020 · Debt: $32.7M2021 · Cash: $108.5M2021 · Debt: $66.6M2022 · Cash: $161.4M2022 · Debt: $64.2M2023 · Cash: $696.1M2023 · Debt: $87.9M2024 · Cash: $543.1M2024 · Debt: $135.8M2025 · Cash: $383.7M2025 · Debt: $158.7M20182025
CashDebt
Profitability
2018 · Gross margin: +100.0%2019 · Gross margin: +100.0%2020 · Gross margin: +100.0%2021 · Gross margin: +100.0%2022 · Gross margin: +100.0%2023 · Gross margin: +100.0%2024 · Gross margin: 0.0%2025 · Gross margin: 0.0%2018 · Operating margin: -200.0%2019 · Operating margin: -108.2%2020 · Operating margin: -257.5%2021 · Operating margin: -639.7%2022 · Operating margin: -730.0%2023 · Operating margin: -4,207.1%2024 · Operating margin: 0.0%2025 · Operating margin: 0.0%2018 · Net margin: -207.2%2019 · Net margin: -95.2%2020 · Net margin: -251.6%2021 · Net margin: -636.6%2022 · Net margin: -703.0%2023 · Net margin: -3,768.3%2024 · Net margin: 0.0%2025 · Net margin: 0.0%20182025
Gross marginOperating marginNet margin
Revenue growth
2019: +148.2%2020: -14.1%2021: -31.6%2022: +20.4%2023: -67.3%2024: -100.0%20182025
Shares outstanding
2018: 36.5M2019: 36.5M2020: 66.6M2021: 72.8M2022: 80.6M2023: 113.1M2024: 167.7M2025: 190.1M20182025
Valuation
2018 · P/E: -25.12019 · P/E: -22.12020 · P/E: -24.42021 · P/E: -10.22022 · P/E: -7.72023 · P/E: -7.42024 · P/E: -12.22025 · P/E: -13.42018 · P/S: 52.32019 · P/S: 21.12020 · P/S: 61.32021 · P/S: 62.42022 · P/S: 54.32023 · P/S: 280.22024 · P/S: 0.02025 · P/S: 0.020182025
P/EP/S

Refreshed 2h ago

Next catalyst

Catalysts

Earnings
2026-11-04
Revenue est. $16.9M · Updated 2h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-9.72$165.8M-17
FY 2027-5.74$1.1B-17
FY 2028-1.78$2.5B-17
FY 20295.95$4.6B-12
FY 203013.54$6.9B-7
Q1 2027-1.75$196.5M-5

Company events

6
2026-11-04EarningsActual - / Estimate -2.43-
2026-08-05EarningsActual -3.06 / Estimate -2.04Miss
2026-05-06EarningsActual -2.29 / Estimate -1.84Miss
2026-02-25EarningsActual -1.86 / Estimate -1.58Miss
2025-11-05EarningsActual -1.61 / Estimate -1.42Miss
2025-08-06EarningsActual -1.31 / Estimate -0.94Miss

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
CRWV$44.2B5.8-22.2-25.4%21COIN$46.2B8.3-47.4-17.8%28PYPL$46.8B1.410.3+14.4%12ALAB$47B39.1126.3+30.7%16CBRS$41.8B61.4-56.6-75.3%23LYV$41.8B1.6-163.3+0.5%1ROK$47.3B5.339.8+13.4%4EBAY$47.4B3.921.6+18.5%11